Jane Henderson's Net Worth
$12.1 Million
Who is Jane Henderson?
Jane Henderson has an estimated net worth of $12.1 Million. This is based on reported shares across multiple companies, which include Adagio Therapeutics, Inc., Voyager Therapeutics, Inc., Akero Therapeutics, Inc., Ophthotech Corp., Eleven Biotherapeutics, Inc., PANACOS PHARMACEUTICALS, INC., Apogee Therapeutics, Inc., and CARGO Therapeutics, Inc..
SEC CIK
Jane Henderson's CIK is 0001422304
Past Insider Trading and Trends
2018 was Jane Henderson's most active year for acquiring shares with 8 total transactions. Jane Henderson's most active month to acquire stocks was the month of May. 2023 was Jane Henderson's most active year for disposing of shares, totalling 12 transactions. Jane Henderson's most active month to dispose stocks was the month of February. 2023 saw Jane Henderson paying a total of $280,400.00 for 252,433 shares, this is the most they've acquired in one year. In 2023 Jane Henderson cashed out on 242,862 shares for a total of $2,166,684.66, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Adagio Therapeutics, Inc. (IVVD) Snapshot price: $0.822
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Voyager Therapeutics, Inc. (VYGR) Snapshot price: $6.13
Sr. V.P. & CFO, Corp. Dev.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$16.42 | -$276,850.00 |
0
|
Mar 22 - Mar 23
| |||
Form 4
|
—
|
0
|
$17.04 | -$175,535.88 |
0
|
Mar 16 - Mar 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Akero Therapeutics, Inc. (AKRO) Snapshot price: $26.41
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 23
| |||
Form 4
|
—
|
0
|
$30.59 | -$1,886,284.65 |
0
|
Jun 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Ophthotech Corp. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -22.09K |
—
|
—
|
0
|
Jul 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 17
| |||
Form 4
| +194.51% | 14.59K |
—
|
—
| 22.09K |
May 11
| |||
Form 4
|
∞
| 7.5K |
—
|
—
| 7.5K |
May 11 - May 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Eleven Biotherapeutics, Inc. (CARM) Snapshot price: $0.9803
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |